Nanoparticulate diagnostic mixed carboxylic anhydrides as X-ray

Details Nanoparticulate diagnostic mixed carboxylic anhydrides as X-ray Nanoparticulate diagnostic mixed carboxylic anhydrides as X-ray

1995-03-09

1996-11-12

Clardy, S. Mark

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

X-ray contrast imaging agent

558276, 562887, A61K 4904, C07C 6996, C07C 6368

Patent

active

055737498

ABSTRACT:
This invention relates to methods of x-ray diagnostic imaging the blood pool, liver, spleen, and/or lymph system of a mammal comprising administering a contrast effective amount of a mixed carbonic anhydride as a contrast agent having the structure ##STR1## X is H, NR.sup.1 R.sup.2 or CONR.sup.1 R.sup.3, R.sup.1 is H or alkyl

REFERENCES:
patent: 3097228 (1963-07-01), Larsen
patent: 4607123 (1986-08-01), Schuster et al.
patent: 5318767 (1994-06-01), Liversidge et al.
Swanson et al, "Pharmaceuticals in Medical Imaging", 1990, MacMillan Publishing Company.
Chemical Abstract 149397-07-9 (1994).
Chemical Abstracts 105: 60940, 1985.

Affiliated with

Also associated with

Rating

Nanoparticulate diagnostic mixed carboxylic anhydrides as X-ray does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nanoparticulate diagnostic mixed carboxylic anhydrides as X-ray , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoparticulate diagnostic mixed carboxylic anhydrides as X-ray will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-560509